Status:
COMPLETED
Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19)
Lead Sponsor:
University Hospital, Montpellier
Conditions:
COVID-19
Pneumonia
Eligibility:
All Genders
18-99 years
Brief Summary
Acute respiratory distress syndrome (ARDS) is a syndromic definition of an acute lung injury with alteration of biomechanics (lower respiratory system compliance) mostly associated with increased lesi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- COVID-19 critically ill patients
- Invasive mechanical ventilation
- Exclusion criteria:
- Age under 18
- Pregnancy
- Legally protected adults
- Contra-indication of using PiCCO device: jugular venous thrombosis, or severe chronic femoral/iliac artery occlusive disease
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04376905
Start Date
April 1 2020
End Date
September 30 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295